Page last updated: 2024-09-05

ec 27 and saralasin

ec 27 has been researched along with saralasin in 2 studies

Compound Research Comparison

Studies (ec 27)	Trials (ec 27)	Recent Studies (post-2010) (ec 27)	Studies (saralasin)	Trials (saralasin)	Recent Studies (post-2010) (saralasin)
5	0	0	1,497	13	16

Protein Interaction Comparison

Protein	Taxonomy	saralasin (IC50)
Type-1A angiotensin II receptor	Rattus norvegicus (Norway rat)	0.0017
Type-1B angiotensin II receptor	Rattus norvegicus (Norway rat)	0.0017
Type-1 angiotensin II receptor	Homo sapiens (human)	0.0006
Type-2 angiotensin II receptor	Homo sapiens (human)	0.0008

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chauvel, E; Corvol, P; Fournie-Zaluski, MC; Llorens-Cortes, C; Roques, BP; Zini, S	1
Llorens-Cortes, C	1

Other Studies

2 other study(ies) available for ec 27 and saralasin

Article	Year
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proceedings of the National Academy of Sciences of the United States of America, 1996, Oct-15, Volume: 93, Issue:21 Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Injections, Intraventricular; Kinetics; Male; Mice; Protease Inhibitors; Saralasin; Substrate Specificity; Sulfhydryl Compounds; Sulfonic Acids; Time Factors; Vasopressins	1996
[Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1998, Volume: 192, Issue:4 Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Brain; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Half-Life; Hypothalamus; Injections, Intraventricular; Male; Mice; Protease Inhibitors; Saralasin; Sulfhydryl Compounds; Sulfonic Acids; Vasopressins	1998

Article

Year

Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

Proceedings of the National Academy of Sciences of the United States of America, 1996, Oct-15, Volume: 93, Issue:21

Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Injections, Intraventricular; Kinetics; Male; Mice; Protease Inhibitors; Saralasin; Substrate Specificity; Sulfhydryl Compounds; Sulfonic Acids; Time Factors; Vasopressins

1996

[Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].

Comptes rendus des seances de la Societe de biologie et de ses filiales, 1998, Volume: 192, Issue:4

Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Brain; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Half-Life; Hypothalamus; Injections, Intraventricular; Male; Mice; Protease Inhibitors; Saralasin; Sulfhydryl Compounds; Sulfonic Acids; Vasopressins

1998